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Abstract 28 
Oleanolic (OA) and maslinic (MA) acids are two natural triterpenoids with a wide range 29 
of beneficial effects for human health. However, their low solubility and permeability 30 
make their application in the food or pharmaceutical industry difficult. The complexation 31 
of OA and MA with - -, -, HP--, HP-- and HP--CDs under different pH and 32 
temperature conditions has been studied. Neither - nor HP--CDs formed inclusion 33 
complexes, while -, HP-- and HP--CDs provided AL type and -CDs BS phase 34 
solubility diagrams. Complexation was shown to be more stable in the case of MA but 35 
complexation efficiency was greater for OA. Increasing the pH and temperature of the 36 
complexation media tended to improve the complexation process with triterpenic acids.   37 
 38 
1. Introduction 39 
 Oleanolic acid (OA) and maslinic acid (MA) are two natural pentacyclic 40 
triterpenoids widely distributed in nature (Fig. 1 Ai and Fig. 2 Ai). Many previous studies 41 
indicate that these compounds are naturally present, in both free and glycosylated forms, 42 
in hundreds of plants species (Somova, Nadar, Rammanan & Shode, 2003; Fai & Tao, 43 
2009; Gao, Tang & Tong, 2012; Lin, Yan & Yin, 2014), as well as in other organisms 44 
such as bacteria, fungi and yeasts (Parra et al, 2014). One of the plant species in which 45 
these compounds are particularly plentiful is the olive tree, and significant quantities are 46 
found in the by-products resulting from the olive oil extraction. Chouaïb et al. (2015) 47 
studied the concentration of OA and MA in olive pomace from different olive tree 48 
varieties, finding values of between 0.19 and 3.40 mg/g DW, and between 0.29 and 8.50 49 
mg/g DW for OA and MA, respectively. 50 
The biological and chemical properties of natural triterpenes, as well as their 51 
derivatives, have been widely studied in recent years. Around 40 % of all scientific 52 
publications related to the biology and chemistry of these compounds were published 53 
between 2010 and 2015 (Sommerwerk, Heller, Kuhfs & Csuk, 2016), with an upward 54 
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trend between these dates (Tasca & Baggio, 2017). The huge interest in OA and MA lies 55 
in their broad spectrum of biological properties. Many studies highlight their role as 56 
hepatoprotectives (Chen, Liu, Yang, Zhao & Hu, 2005; Yan, Yang, Lee & Yin, 2014), 57 
inhibitors of rheumatoid arthritis (Choi et al., 2016), and their antimicrobial (Kurek, 58 
Nadkowska, Pliszka & Wolska, 2012; Chouaïb et al., 2015), anticarcinogenic (Lin et al., 59 
2014; Chouaïb et al., 2016), anti-inflammatory (Chouaïb et al., 2016), antidiabetic 60 
(Castellano, Guinda, Rada, Delgado & Cayuela, 2013) and antiviral (anti-HIV) (Parra et 61 
al., 2014) actions. 62 
The main disadvantage of these compounds for application in food or 63 
pharmaceutical industry as functional ingredients is their low aqueous solubility and 64 
permeability. A variety of values for the water solubility of OA have been reported by 65 
different authors. Jäger, Winkler, Pfüller and Scheffler (2007) established the water 66 
solubility of OA as 0.02 g/mL, and Li, Quan, Liu, Wei, Zhang and Xu (2009) concluded 67 
that its aqueous solubility was lower than the detection limit of their methodology used 68 
(<0.1 g/mL). However, other authors indicated higher aqueous solubility values, 69 
including 4.61 g/mL at 20 ºC (Gao et al., 2012). No values for the aqueous solubility of 70 
MA have been found in the literature. The permeability value of OA (Papp = 1.1-1.3 x 71 
10-6 cm/s in the apical-to-basolateral direction at 10 and 20 M) has been mentioned by 72 
some authors (Jeong et al., 2007). This combination of low solubility and permeability 73 
means that these triterpenoids are of low bioavailability. Another disadvantage associated 74 
with poor aqueous solubility is the need to use organic solvents such as cyclohexane, 75 
ethyl acetate, methanol, acetonitrile or acetone for their extraction from plant material 76 
(Bernatoniene, Cizauskaite, Ivanauskas, Jakstas, Kalveniene & Kopustinskiene, 2016; 77 
Tasca & Baggio, 2017). 78 
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Several efforts have focused on improving the bioavailability and extractability of 79 
OA and MA by increasing their aqueous solubility. Chen, Zhong, Tan, Wang and Wnag 80 
(2011) determined that solid-liquid nanoparticles improve the bioavailability of the OA. 81 
An increase in pH has also been proposed for increasing the solubility of these 82 
compounds. For example, Jäger et al. (2007) increased the water solubility of OA to 77.2 83 
g/mL by increasing the water pH to 11.5. Jiang, Yang, Du, Zhang and Zhang (2016) 84 
significantly increased the solubility of OA by the formation of solidified phospholipid 85 
complexes with hydroxyapatite. Other techniques studied to increase the aqueous 86 
solubility of these compounds have been the particle size reduction, solid dispersion, 87 
cosolvency, salt formation and the combination of any of them (Loftsson, Jarho, Másson 88 
& Järvinen, 2005). 89 
Complexation with cyclodextrins (CDs) has been widely used to increase the 90 
aqueous solubility of different compounds (Lucas-Abellán, Fortea, Gabaldón & Núñez-91 
Delicado, 2008; Mercader-Ros, Lucas-Abellán, Fortea, Gabaldón and Núñez-Delicado, 92 
2010a; Mercader-Ros, Lucas-Abellán, Gabaldón, Fortea, Martínez-Cachá, Núñez-93 
Delicado, 2010b), and to improve the extraction of compounds with a poor aqueous 94 
solubility from food by-products (Lopez-Miranda et al., 2016). Chen, Wu, Li and  Cheng 95 
(2010) improved the extraction of OA from leaves of Chaenomeles speciosa by using 96 
HP--CDs. Li et al. (2009) observed that the concentration of extracted OA increased 97 
from 0.08 mmol/L to 2.15 mmol/L when the concentration of HP--CDs increased from 98 
5 mmol/L to 60 mmol/L. In a study developed by Quan, Liu, Li, Zhang, Qian and Xu 99 
(2009), it was observed that the combination of HP--CDs with water soluble polymers 100 
(HPMC and PVP) improved the aqueous solubility of OA and its isomer ursolic acid. 101 
CDs may be regarded as suitable tools for improving the aqueous solubility of 102 
triterpenic acids, especially OA and MA. However, previous studies have mainly focused 103 
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on OA and its interaction with HP--CDs, and there is no information about other CDs 104 
types or different complexation conditions. For this reason, it was thought necessary to 105 
improve our knowledge on the complexation mechanism between OA and MA with 106 
different types of CDs, as well as different complexation conditions such as pH or 107 
temperature. 108 
The aim of this work was to study the complexation behavior of OA and MA with 109 
natives - - or -CDs as well as their modified HP--, HP-- or HP--CDs, and the 110 
effect of pH and temperature on the complexation process. 111 
 112 
2. Material and Methods 113 
2.1. Reagents and standards 114 
 OA (94% purity) and MA (83.4 % purity) were commercial extracts provided by 115 
Nutrafur S.A. (Murcia, Spain). Acetonitrile and water of HPLC grade were purchased 116 
from JT Baker (The Netherlands). The - -, -, HP--, HP-- and HP--CDs were 117 
purchased form Winplus International Limited (China). Reagent grade acetic and boric 118 
acids were purchase from Sharlau (Tarragona, Spain), and potassium di-hydrogen 119 
phosphate (reagent grade) were purchased from Panreac (Barcelona, Spain). 120 
 121 
2.2. Complexation and phase solubility diagrams 122 
The complexation process of OA and MA were evaluated by developing phase 123 
solubility diagrams, according to a modified method of that described by Higuchi and 124 
Connors (Higuchi & Connors, 1965). Excess amounts of OA and MA were added to 10 125 
mL of aqueous solutions of increasing concentrations from 0 to 13 mM for -CDs and 0 126 
6 
 
to 50 mM for -, -, HP--, HP-- and HP--CDs. The different phase solubility diagrams 127 
were prepared in glass test tubes and maintained in an ultrasonic bath (Ultrasons H.P. 128 
Selecta, Spain) for 60 min to reach equilibrium.  129 
The effect of temperature on the complexation process was studied by developing 130 
solubility experiments in distilled water at different temperatures (4 ºC, 25 ºC and 65 ºC). 131 
The effect of pH on the complexation process was studied by developing solubility 132 
diagrams in buffered solutions of CDs at pH 3.0 (sodium acetate buffer), 6.5 (sodium 133 
phosphate buffer) and pH 9 (sodium borate buffer). 134 
After 60 min of ultrasound treatment, solutions were centrifuged in a 135 
microcentrifuge (Eppendorf Centrifuge S415D, Germany) at 10000 xg for 10 minutes and 136 
filtered using 0.45 m nylon membrane filters (Chromafil. Macherey-Nagel, Germany). 137 
Phase solubility diagrams were made in triplicate. 138 
The complexation constant Kc between the triterpenic acids and CDs was 139 
calculated from the slope of the phase solubility profile and the solubility of the triterpenic 140 
acid in aqueous solution (S0) by using the equation (1): 141 
)1·( slopeS
slopeK
o
C    (1) 142 
 The complexation efficiency (CE) is the ratio between dissolved complex and free 143 
CDs concentration. It is independent of S0, and was calculated from the slope of the phase 144 
solubility profiles by using the equation (2). 145 
 
  %100)1(*0 xslope
slopeKS
CD
complexdisolvedCE C
f 
  (2) 146 
 The molar ratio OA:CD and MA:CD was calculated using the CE value with the 147 
equation (3). 148 
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Triterpenic Acid:CD 

 
CE
11:1 (3) 149 
 150 
2.3. Thermodynamic parameters of the complexation process 151 
The thermodynamic parameters calculated were the Gibbs free energy transfer 152 
(G0tr), standard free energy change (G0), standard enthalpy change (H0), and standard 153 
entropy change (S0).  154 
The G0tr represents the free energy of transferring a compound from water to the 155 
CD hydrophobic cavity, and was calculated by equation (4). 156 
0
0 ·ln
S
SRTGtr  (4) 157 
in which S is the molar solubility of OA or MA in a CDs aqueous solution, R is the gas 158 
constant and T is the absolute temperature in K.  159 
The G0 values of the complexation reaction were calculated from the Kc using 160 
the equation (5). 161 
CKRTG ·log303.20  (5) 162 
The H0 values were also calculated from Kc by using the van’t Hoff equation 163 
(6): 164 
C
TR
HLogKC  1·303.2
0
(6) 165 
 The S0 could be also calculated by using the equation (7): 166 
000 · STHG  (7) 167 
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2.4. OA and MA determination by HPLC  168 
OA and MA were quantified by HPLC analysis using an HPLC Agilent 169 
Technologies model 1200 equipped with a DAD detector set at 203 nm, injecting 20 L 170 
of centrifuged and nylon filtered complexes. Separations were carried out on an 171 
endcapped (5 m) HPLC Cartridge 250-4 LiChospher 100 RP-18. The column 172 
temperature was set to 30 ºC, and the flow rate was 1 mL/min. The mobile phase used 173 
was water (A) versus acetonitrile (B) for a total running time of 26 min, during which the 174 
gradient changed as follows: solvent B was maintained at 70 % from 0 to 10 min, then 175 
increased to 80 % and maintained for 13 min, before returning to initial conditions in 3 176 
min. Time retentions were 9.1 min for MA and 19.9 min for OA. The data were processed 177 
by Agilent ChemStation software, and the OA and MA concentrations were expressed in 178 
mM.  179 
 180 
3. Results and discussion 181 
3.1. Complexation of OA and MA  182 
In order to study the ability of CDs to increase the aqueous solubility of OA and 183 
MA, phase solubility studies were carried out in distilled water at 25 ºC with different 184 
types of native and modified CDs. The results obtained by using these types of CDs are 185 
shown in Fig. 1 and 2 (■) for OA and MA, respectively. 186 
 The presence of α- or HP-α-CDs did not increase the aqueous solubility of OA or 187 
MA, indicating that inclusion complexes were not formed, probably due to the small size 188 
of the hydrophobic cavity of these two types of CDs (data not shown).  189 
In the case of β- and HP-β-CDs, the phase solubility diagrams showed an AL type 190 
profile, for both OA (Fig. 1A and 1B) and MA (Fig. 2A and 2B), indicating that water 191 
9 
 
soluble complexes were formed. The slope value was lower than 1 in all cases, indicating 192 
the 1:1 stoichiometry of the complexes (Higuchi & Connors, 1965), whereby each 193 
molecule of OA or MA enters one molecule of the CD. Li et al. (2009) observed an AL- 194 
diagram for OA and HP--CDs and suggested that this kind of diagram could be normal 195 
for compounds with low water solubility. 196 
 Assuming the formation of 1:1 complexes, the complexation constant (Kc) was 197 
calculated by using linear regression analysis from the phase solubility diagrams 198 
according to equation (1). Kc values in water at 25 ºC are shown in table 1 (T 25 ºC).  199 
 The Kc value obtained was higher for native than for modified CDs in both OA 200 
and MA, indicating a greater affinity of the native β-CDs for the triterpenic acids 201 
compared to their modified HP-β-CDs. The Kc value obtained for the β-CDs-OA 202 
complex was 825 M-1 whereas in the case of HP-β-CDs the Kc value was 201 M-1. In the 203 
case of MA, the Kc values were quite similar: 2653 and 2537 M-1 for - and HP--CDs, 204 
respectively. Chemical modification by adding hydroxypropyl groups to native β-CDs 205 
does not favour its capacity to entrap OA or MA in the hydrophobic cavity. These results 206 
agree with those obtained for oxaliplatin, when β-CDs showed higher Kc (1438 M-1) than 207 
HP-β-CDs (664 M-1) (Zhang et al., 2016). However, the results contrast with those 208 
obtained for many other compounds, such as resveratrol (Lucas-Abellán et al., 2008) or 209 
diazepam and nitrazepam (Hadžiabdić, Elezović, Rahić & Mujezin, 2012). It is important 210 
to note that the stability of the complexes formed between β- or HP-β-CDs and MA were 211 
higher than those formed with OA as their Kc values indicated. This fact might well be 212 
due to the presence of an additional OH group in the chemical structure of MA, which 213 
would interact with the surrounding OH groups of the CD cavity. 214 
 In the case of native γ-CDs, phase solubility diagrams obtained for both OA and 215 
MA were of the BS type (Fig. 1C and 2C). This type of phase solubility diagrams indicated 216 
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that the solubility of triterpenic acids increased with CDs concentration until reaching a 217 
maximum, before remaining constant or decreasing for higher CDs concentrations. The 218 
complexes formed with γ-CDs presented limited solubility (approx. 0.15 mM), 219 
decreasing in the presence of γ-CDs concentrations above 2.5 mM for OA (Fig. 1C), and 220 
5 mM for MA (Fig. 2C). This effect could be explained by the formation of 221 
supramolecular complexes of high molecular weight that precipitate (more than one γ-222 
CDs is added to formed complexes). This BS type phase solubility diagram contrast with 223 
those of the AL type obtained for the complexation of picoplatin (Zhang et al., 2014), 224 
fisetin (Zhang et al., 2015) or oxaliplatin (Zhang et al., 2016) with γ-CDs. 225 
The value of Kc for γ-CDs was calculated from the initial linear portion of the 226 
phase solubility diagrams, from 0 to 1 mM (Fig. 1Ci and 2Ci), for which the slope value 227 
was lower than 1, indicating that the stoichiometry of the complexes formed was 1:1. The 228 
Kc values obtained were 4895 M-1 for OA and 18723 M-1 for MA (Table 1, T 25 ºC), 229 
which indicated that the interaction between the triterpenic acids and γ-CDs was much 230 
stronger than the corresponding interactions observed in the case of β-CDs. It is also 231 
important to point that the complexes formed between MA and γ-CDs were more stable 232 
than those formed with OA, as indicated by the higher Kc value obtained. As in the case 233 
of β-CDs, this could also be due to the presence of an additional OH group in the chemical 234 
structure of MA, which would interact with the surrounding OH groups of the CD cavity. 235 
The Kc values obtained between γ-CDs and OA or MA were higher than those obtained 236 
for oxaliplatin (1322 M-1, Zhang et al., 2016) or fisetin (196 M-1, Zhang et al., 2015), 237 
while in the case of picoplatin (10318 M-1, Zhang et al., 2014), OA showed a lower Kc 238 
value, and MA a higher value. 239 
 As regard the behaviour of HP-γ-CDs, AL type diagrams were obtained for both 240 
OA and MA (Fig. 1D and 2D), indicating the high water solubility of the complexes 241 
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formed in contrast with those obtained for native γ-CDs. The slope of the diagram was 242 
lower than 1 for both triterpenic acids, thus indicating a 1:1 stoichiometry of the 243 
complexes formed (Higuchi & Connors, 1965), as usually occurs in the case of modified 244 
CDs (Zhang et al., 2016). The Kc values for HP--CDs complexes formed in pure water 245 
were 645 M-1 and 5474 M-1 for OA and MA, respectively (Table 1, T 25 ºC). The value 246 
obtained for OA was similar and that obtained for MA was higher than that obtained for 247 
oxaliplatin (664 M-1) (Zhang et al., 2016). These values are much lower than those 248 
obtained with the native -CD. 249 
 The Kc value describes the strength of the interaction between any compound and 250 
CDs, and can be used to compare the affinity of any compound for different CDs types. 251 
But a more accurate parameter for the determination of the solubilizing effect of CDs is 252 
their complexation efficiency (CE) because it is independent on S0 (Li et al., 2009). CE 253 
represents the molar ratio between complex and free CDs concentration (Loftsson & 254 
Hreinsdóttir, 2007). For 1:1 complexes, the CE can be calculated from the slope of phase 255 
solubility diagram with equation (2) (Loftsson & Brewster, 2010; Loftsson & Brewster, 256 
2012). 257 
The comparison of CE parameters is more convenient than comparing Kc values 258 
when the study involves different types of CDs or different complexation conditions for 259 
the same compound. In this study, CE was also used to calculate the OA:CD and MA:CD 260 
molar ratio in solution with equation (3), which can be correlated to the expected increase 261 
in compound solubility with different CDs (Loftsson & Hreinsdóttir, 2007). The values 262 
obtained for CE and molar ratio are shown in table 1 (T 25 ºC). 263 
For the complexation of OA in water at 25 ºC, the CE values obtained ranged from 264 
0.52 % for HP-β-CDs to 12.7 % for γ-CDs. The most effective CDs in the complexation 265 
of OA were -CDs, indicating that about one of every 9 γ-CDs molecules in solution is 266 
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forming water soluble complexes, as the molar ratio value indicated for this CD type 267 
(Molar ratio of 1:9, Table 1, T 25 ºC). However, only one of every 193 HP-β-CDs 268 
molecules in solution forms water soluble complexes with OA (Molar ratio 1:193, Table 269 
1, T 25 ºC). 270 
The same behaviour was observed for MA, in which the lowest value of CE was 271 
obtained for HP-β-CDs (0.89 %) and the highest for γ-CDs (6.25 %), indicating that -272 
CDs are also the most effective for the complexation of MA. About one in every 16 γ-273 
CDs molecules in solution forms water soluble complexes with MA (Molar ratio 1:16, 274 
Table 1, T 25 ºC), while one in every 113 HP-β-CDs molecules in solution forms water 275 
soluble complexes (Molar ratio 1:113, Table 1, T 25 ºC). 276 
Comparing the OA and MA results obtained for γ-CDs, OA showed a higher CE 277 
(12.7 % vs 6.25 %) and a lower molar ratio (1:9 vs 1:16) than MA, indicating that 278 
complexation with OA was more effective, although MA-γ-CDs complexes were more 279 
stable as indicated its higher Kc value (4895 M-1 for OA vs 18723 M-1 for MA). 280 
 281 
3.2. Effect of temperature on complexation of OA and MA. Thermodynamic parameters 282 
The influence of temperature on the complexation process of OA and MA with 283 
native or modified CDs was also studied. As can be seen in table 1, the Kc value for the 284 
triterpenic acids with each type of CDs used increased with temperature, indicating that 285 
higher temperatures favour entrapment of the triterpenic acids in the hydrophobic cavity 286 
of CDs.  287 
 The thermodynamic parameters were calculated from phase solubility diagrams 288 
in the presence of increasing concentrations of CDs at several temperatures (Fig. 1 and 289 
2). The Gibbs free energy of transfer (G0tr) represents the free energy of transfer of a 290 
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compound from water to the CDs cavity and provides information about whether the 291 
reaction condition is favourable or unfavourable for the solubilisation in the aqueous 292 
carrier solution. The G0tr values with increasing concentrations of CDs were calculated 293 
using equation (4) (Hadžiabdić et al., 2012).  294 
The negative values of G0tr obtained in all cases indicated the spontaneous 295 
inclusion of OA and MA in each type of CD (Table 2). Moreover, in all the CD types 296 
studied G0tr values were more negative as CDs concentration increased, indicating that 297 
the reaction was more favourable as the CD concentration increased. Similar results were 298 
described for diazepam and nitrazepan (Hadžiabdić et al., 2012).  299 
 All the thermodynamic parameters obtained are shown in table 2, where it can be 300 
seen that OA and MA solutions in the presence of β-, γ-, HP-β- or HP-γ-CDs were 301 
characterized by negative G0 values, indicating the spontaneous complexation of the 302 
triterpenic acids in the hydrophobic cavity of each CD (Karathanos, Mourtzinos, 303 
Yannakopoulou & Andrikopoulos, 2007). Similar results have been described for 304 
diazepan, nitrazepan or carvacrol (Hadžiabdić et al., 2012; Santos, Kamimura, Hill & 305 
Gomes, 2015). The G0 values increased in the following order for OA: γ-CDs< β-CDs< 306 
HP-γ-CDs< HP-β-CDs and for MA: γ-CDs< HP-γ-CDs< β-CDs< HP-β-CDs. In both 307 
cases, the order agrees with the order in the decrease of Kc values. In other words, the 308 
lower the G0, the higher the Kc value.  309 
Moreover, the positive values of H0 obtained for OA or MA with all the CD 310 
types used also indicated the endothermic reaction (Connors, 2002). The values of H0 311 
increased in the same order as G0 and so in the reverse order of the Kc values, indicating 312 
that complexation with higher Kc values were less endothermic and had more negative 313 
values for G0 (more spontaneous reaction). 314 
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The positive values obtained for S0 could be due to the entry of OA or MA in 315 
the hydrophobic cavity of CDs governed by hydrophobic interactions, which involve a 316 
breakdown of the water structure around the OA or MA, creating a large positive S0 and 317 
a small positive H0. These results agree with those described for diazepam and 318 
nitrazepan (Hadžiabdić et al., 2012). 319 
 320 
3.3. Effect of pH on complexation of OA and MA 321 
 Different pH values determine the presence of neutral or protonated OA or MA 322 
forms in the solution. Ionization may significantly influence their solubility and the 323 
complexation process. The solubility of these triterpenic acids was tested in a pH range 324 
from 3.0 to 9.0 and was seen to slightly increased with pH in both cases (Table 1), as 325 
previously observed by Jäger et al. (2007) for OA. To study the influence of OA and MA 326 
ionization on their complexation process with CDs, phase solubility diagrams were 327 
carried out at different pH values (3.0, 6.5 and 9.0) (Fig. 3 and 4). 328 
With each type of CDs used, the phase solubility diagram profile obtained was 329 
similar to that obtained when using pure water. The experimental data showed that the 330 
Kc increased with the pH of the media (Table 1), indicating the influence of the OA or 331 
MA ionization in the complexation process. These results were similar to those obtained 332 
in the case of risperidone (Jug, Kos & Bećirević-Laćan, 2009). Despite the fact that 333 
ionized forms of triterpenic acids (pH 9.0) were slightly more soluble than the non-334 
deprotonated forms, the higher Kc values obtained at pH 9.0, were probably due to that 335 
the protonated form establishing stronger interactions with the hydrophobic cavity of each 336 
CDs. OA and γ-CDs at pH 9.0 showed the highest Kc value, 38482 M-1 (20-fold higher 337 
than at pH 3.0) (Table 1). 338 
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 As solubility and Kc values varied with the pH value of the medium, it was 339 
thought that the CE would also be affected by this parameter. Indeed, for all the CD types 340 
studied, CE clearly increased with pH value for both OA and MA (Table 1). The highest 341 
CE value obtained was 134 % for OA and γ-CDs at pH 9.0, indicating that at this basic 342 
pH one of every 2 γ-CDs molecules in solution forms water soluble complexes (molar 343 
ratio 1:2, Table 1). This CE value was 47-fold higher than that obtained for OA and γ-344 
CDs at pH 3.0. In contrast, the lowest CE value obtained was 0.15 % for MA and β-CDs 345 
at pH 3.0, indicating that at this acid pH one in every 668 β-CDs molecules in solution is 346 
forming water soluble complexes with MA (molar ratio 1:668, Table 1). HP--CD and 347 
MA showed similar values to those observed for -CD. 348 
 In conclusion, this paper shows that, due to their low aqueous solubility and 349 
chemical structure, OA and MA are complexed by β-, γ-, HP-β- or HP-γ-CDs, but not by 350 
- or HP--CDs. Contrary to expectations, native β- and γ-CDs exhibited higher Kc 351 
values than their corresponding HP modified CDs, indicating the higher strength of the 352 
interaction between OA or MA with native than with modified CDs. In both OA an MA, 353 
γ-CDs showed a BS type phase solubility diagram, and presented the highest Kc values 354 
(6-fold greater than that presented by β-CDs for OA and 7-fold in the case of MA). As 355 
CE values represent the solubilizing potential of CDs, the values obtained indicate that a 356 
high Kc value does not always correspond with a high CE value because of the influence 357 
of S0 on the Kc value. For this reason, it is more accurate to use the CE to study the effect 358 
of physical or chemical parameters which affect S0 in the encapsulation process. The pH 359 
and temperature affected to the complexation process of OA and MA. The deprotonate 360 
form of OA or MA at pH 9.0 forming the most stable union with γ-CDs. Moreover, an 361 
increase in the temperature of the medium resulted in an increase in complex formation 362 
with both OA and MA. Therefore, these results pointed to the fact that in order to extract 363 
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both OA and MA from food by-products like those derived from olive oil production, 364 
basic pH, temperatures from 50 to 60 ºC and -CDs should provide properly results for 365 
industry scale extractions.  366 
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Table 1. Aqueous solubility (S0), complexation constant (Kc), correlation coefficient of 509 
the phase solubility diagram (r2), complexation efficiency (CE) and Molar Ratio (D:C), 510 
of oleanolic and maslinic acid for different CDs, Temperatures (T) and pH. ±SD. Standard 511 
deviation of triplicate diagrams.  512 
   Oleanolic Acid Maslinic Acid 
   S0 
(M) 
Kc 
(M-1) r2 
CE 
(%) 
Molar 
Ratio 
(D:C) 
S0 
(M) 
Kc 
(M-1) r2 
CE 
(%) 
Molar 
Ratio 
(D:C) 
-CD 
T 
4ºC 14±0.9 729±15 0.966 1.02 1:99 2.8±0.2 2119±102 0.999 0.59 1:169 
25ºC 26±1.2 825±17 0.990 2.15 1:47 3.5±0.4 2653±82 0.989 0.93 1:108 
65ºC 33±0.9 953±7 0.998 3.15 1:33 4.0±0.3 3062±465 0.997 1.22 1:83 
pH 
3.0 14±1.0 605±21 0.975 0.85 1:119 2.1±0.2 7152.1±68 0.968 0.15 1:668 
6.5 24±1.3 613±20 0.970 1.53 1:66 3.0±0.4 4493±194 0.964 1.35 1:75 
9.0 35±2.5 1882±14 0.992 6.59 1:16 5.0±0.7 11909±507 0.990 5.95 1:18 
HP--CD 
T  
4ºC 14±0.9 71.5±10 0.974 0.10 1:1001 2.8±0.2 1758±77 0.990 0.49 1:204 
25ºC 26±1.2 201±11 0.995 0.52 1:193 3.5±0.4 2537±62 0.994 0.89 1:113 
65ºC 33±0.9 322±43 0.991 1.06 1:95 4.0±0.3 3293±181 0.997 1.32 1:77 
pH 
3.0 14±1.0 518±10 0.981 0.73 1:139 2.1±0.2 763±68 0.975 0.16 1:625 
6.5 24±1.3 340±9 0.999 0.82 1:123 3.0±0.4 1911±72 0.998 0.57 1:176 
9.0 35±2.5 796±41 0.936 2.79 1:37 5.0±0.7 1288±57 0.987 0.64 1:157 
-CD 
T 
4ºC 14±0.9 4721±578 0.999 6.61 1:16 2.8±0.2 17496±278 0.998 4.90 1:21 
25ºC 26±1.2 4895±207 0.999 12.7 1:9 3.5±0.4 18723±1559 0.999 6.25 1:16 
65ºC 33±0.9 5147±293 0.997 17.0 1:7 4.0±0.3 21355±441 0.995 8.54 1:12 
pH 
3.0 14±1.0 2020±133 0.991 2.83 1:36 2.1±0.2 9173±805 0.994 1.93 1:53 
6.5 24±1.3 8468±486 0.981 20.3 1:6 3.0±0.4 17914±968 0.997 5.37 1:19 
9.0 35±2.5 38482±3141 0.954 134 1:2 5.0±0.7 14247±195 0.997 7.12 1:15 
HP--CD 
T 
4ºC 14±0.9 591±67 0.963 0.83 1:122 2.8±0.2 5365±130 0.991 1.50 1:68 
25ºC 26±1.2 645±20 0.994 1.68 1:61 3.5±0.4 5474±314 0.990 1.92 1:53 
65ºC 33±0.9 1220±186 0.977 4.03 1:26 4.0±0.3 7493±187 0.993 3.00 1:34 
pH 
3.0 14±1.0 1548±52 0.992 2.17 1:47 2.1±0.2 5686±84 0.998 1.19 1:84 
6.5 24±1.3 2050±88 0.973 4.92 1:21 3.0±0.4 5248±49 0.991 1.57 1:64 
9.0 35±2.5 8077±362 0.943 28.2 1:5 5.0±0.7 4499±44 0.989 2.25 1:45 
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Table 2. Thermodynamic parameters: Standard Free Energy Chance (G0), Standard 522 
Enthalpy Change (H0) and Standard Entropy Change (S0).  Gibbs free energy of 523 
transfer (G0tr) for the solubilisation process of Oleanolic and Maslinic Acids at 4, 25 and 524 
65 ºC and at different cyclodextrin (CD) concentration (mM). 525 
 526 
Cyclodextrin 
Oleanolic Acid Maslinic Acid 
G0 
(kJ/mol) 
H0 
(kJ/mol) 
S0 
(J/mol) 
G0 
(kJ/mol) 
H0 
(kJ/mol) 
S0 
(J/mol) 
-CD -16.64 3.403 67.26 -19.54 4.546 80.81 
HP--CD -13.14 18.369 105.74 -19.42 7.783 91.30 
-CD -21.05 1.098 74.33 -24.38 2.563 90.40 
HP--CD -16.03 9.617 86.07 -21.33 4.466 86.56 
CD mM G
0tr (kJ/mol) G0tr (kJ/mol) 
4ºC 25ºC 65ºC 4ºC 25ºC 65ºC 
-CD 
2.5 -1.51 -2.37 -3.23 -5.09 -4.87 -5.29 
5.0 -3.07 -3.74 -4.63 -6.46 -6.37 -7.19 
10.0 -4.92 -5.40 -6.56 -7.91 -8.39 -9.05 
13.0 -5.05 -6.15 -7.23 -8.44 -8.82 -9.94 
HP--CD 
5 -0.70 -1.96 -2.68 -6.02 -6.59 -7.49 
15 -2.40 -3.43 -4.77 -8.39 -9.39 -10.47 
30 -3.54 -4.97 -6.70 -9.68 -10.58 -12.17 
50 -4.09 -5.87 -8.35 -11.15 -12.03 -13.86 
-CD 
0.10 -0.96 -1.01 -1.19 -2.97 -2.65 -3.20 
0.25 -1.81 -1.72 -2.27 -4.56 -4.18 -4.48 
0.50 -2.65 -2.88 -3.19 -6.04 -5.55 -6.35 
1.00 -3.90 -4.15 -4.74 -7.36 -7.26 -7.94 
HP--CD 
5 -4.49 -3.92 -6.00 -8.63 -9.01 -10.11 
15 -6.27 -6.13 -8.64 -11.23 -11.38 -12.81 
30 -7.39 -7.51 -9.95 -12.59 -12.58 -14.88 
50 -8.30 -8.57 -- -13.53 -13.82 -15.96 
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Figure 1. Phase solubility diagrams of oleanolic acid with -CD (A), HP--CD (B), -CD 548 
(C and Ci) and HP--CD (D) in aqueous solution at 4 ºC (●), 25 ºC (■) and 65 ºC (▲). 549 
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Figure 2. Phase solubility diagrams of maslinic acid and -CD (A), HP--CD (B), -CD 574 
(C and Ci) and HP--CD (D) in aqueous solution at 4 ºC (●), 25 ºC (■) and 65 ºC (▲). 575 
Maslinic acid chemical structure (Ai). 576 
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Figure 3. Phase solubility diagrams of oleanolic acid and -CD (A), HP--CD (B), -CD 601 
(C and Ci) and HP--CD (D) at pH 3 (●), pH 6.5 (■) and pH 9 (▲) at 25 ºC. 602 
 603 
 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
 612 
A  B 
C  D Ci 
26 
 
 613 
 614 
 615 
 616 
 617 
 618 
 619 
  620 
 621 
 622 
 623 
 624 
 625 
 626 
Figure 4. Phase solubility diagrams of maslinic acid and -CD (A), HP--CD (B), -CD 627 
(C and Ci) and HP--CD (D) at pH 3 (●), pH 6.5 (■) and pH 9 (▲) at 25 ºC. 628 
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